Labcyte company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

labcyte.com

Founded Year

2003

Stage

Acquired | Acquired

Total Raised

$81.57M

About Labcyte

Labcyte is a global biotechnology tools company offering Echo, a liquid handling systems that uses sound to precisely transfer liquids without contact, eliminating the use of pipettes. Labcyte instruments are used throughout the pharmaceutical industry, as well as by biotechnology firms, contract research organizations, and academic institutions. The company's customers work across a wide spectrum of scientific research, including drug discovery, genomics, proteomics, diagnostics, personalized medicine, and imaging mass spectrometry.

Labcyte Headquarter Location

170 Rose Orchard Way

San Jose, California, 95134,

United States

408-747-2000

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Labcyte

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Labcyte is included in 1 Expert Collection, including Omics.

O

Omics

1,267 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data

Labcyte Patents

Labcyte has filed 56 patents.

The 3 most popular patent topics include:

  • Fluid dynamics
  • Acoustics
  • Molecular biology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/1/2020

2/1/2022

Molecular biology, Biotechnology, DNA, Molecular biology techniques, Analytical chemistry

Grant

Application Date

12/1/2020

Grant Date

2/1/2022

Title

Related Topics

Molecular biology, Biotechnology, DNA, Molecular biology techniques, Analytical chemistry

Status

Grant

Latest Labcyte News

Laboratory Automation Systems Global Market Report 2022

May 27, 2022

Major players in the laboratory automation systems market are Tecan Group, Perkinelmer, Thermo Fisher Scientific, Agilent Technologies, Danaher, Qiagen, Roche, Abbott, Siemens, and Eppendorf. May 27, 2022 04:20 ET Lyon, FRANCE New York, May 27, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Laboratory Automation Systems Global Market Report 2022" - https://www.reportlinker.com/p06280847/?utm_source=GNW The global laboratory automation systems market is expected to grow from $5.52 billion in 2021 to $5.87 billion in 2022 at a compound annual growth rate (CAGR) of 6.4%. The market is expected to grow to $6.9 billion in 2026 at a compound annual growth rate (CAGR) of 4.1%. The laboratory automation systems market consists of sales of laboratory automation systems and related services.The laboratory automation system speedup the processes such as drug discovery, vaccine production, and others. Laboratory automation systems include clinical laboratory machines, equipment, and instruments, which analyze and automate many samples in the laboratory with minimal human intervention. The main equipment and software of laboratory automation systems are automated liquid handling, microplate readers, standalone robots, automated storage and retrieval systems, software and informatics, other equipment.The microplate reader is an instrument that is used to measure biological chemical or physical reactions of analytes within the wells of the microplate. The various types include modular automation, total lab automation that is used in applications such as drug discovery, clinical diagnostics, genomics solutions, proteomics solutions, other applications. The end users covered in this market are biotechnology and pharmaceutical industries, research institutes, hospitals, private labs, academic institutes. Increased demand for microbiology testing and standardization of sample-collection devices for microbiology culture has driven the adoption of automated laboratory systems for culture-based laboratory testing in clinical microbiology.Culture-based microbiology laboratory testing by manual methods is being replaced by automated methods with the help of total laboratory automation. For instance, popular systems such as Becton Dickinson’s Kiestra TLA, Copan’s WASPLab, and others enable total laboratory automation (TLA) for culture-based microbiology testing. The potential to affect laboratory efficiency, turnaround time, and the overall quality of culture-based microbiology testing, is driving the automated laboratory systems market growth. The laboratory automation systems market growth is limited due to a severe shortage of skilled and trained healthcare professionals for operating the advanced laboratory equipment which requires specialized skillsets. These skillsets are limited to some hospitals, research organizations, and medical equipment companies in the USA and Europe, this is expected to be a major restraint on the market. 40% of the healthcare industry was facing difficulties in hiring process development staff due to a shortage of talent. According to the American Society for Clinical Pathology (ASCP) survey, average job-vacancy rates exceed 50% in some states. This shortage also led to a rise in competition and salaries for the limited talent pool available, thereby further limiting the market growth. The hospital laboratories are increasingly adopting RFID technology for laboratory automation systems due to its better productivity and product quality reduced costs for technology, error reduction, faster delivery of samples, and reduced human intervention.Radio Frequency Identification (RFID) technology is an automatic system of identification based on wireless communication, consisting of a tag and a reader which can communicate through radiofrequency. RFID technology is similar to bar code technology but is more beneficial as it can perform some additional functions and actions automatically without human intervention than bar code technology.An RFID system is equipped with a transponder, transceiver, and a data processing unit to meet enhanced identification and tracking requirements in hospital laboratories. Laboratory automated systems use RFID tags attached with patient samples for identification and smart cards to store patients’ data under a workstation that monitors the process in the laboratory. For instance, Mayo Clinic, a healthcare company, adopted RFID-enabled laboratory automation systems to minimize errors by 70%, maximize efficiency and patient safety, and reduce specimen turnaround time by 50%. Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH) is responsible for technologies, devices, medical or surgical equipment, support systems, and laboratory instruments, systems, and equipment. FDA sent a device recall notice to enGen Laboratory Automation System, a medical device manufacturer, for its product-enGen Track System with TCAutomation Software Version 4.2. This recall acts as a product correction notification as a laboratory system with TCA Software V4.2 may potentially cause a delay in reporting of results, aid mechanical problems, and inaccurate patient data. To reduce incidences associated with these devices and let the manufacturer communicate and inform about the instructions on how to monitor and correct the issue if it has occurred to the potentially affected enGen customers, the device recall has been made. In January 2019, Beckman Coulter Life Sciences acquired Labcyte for $6.5 billion. This acquisition would strengthen Beckman’s product portfolio and expand the laboratory automation business. Labcyte technology provides lab tools and equipment for Echo acoustic liquid handling technology, Lab automation, software applications, microplates, consumables, and other technologies that enhance time-saving solutions, enable faster, and cost-effective laboratory workflows. Labcyte was founded in 2000 and is headquartered in California. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the laboratory automation systems market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.

  • When was Labcyte founded?

    Labcyte was founded in 2003.

  • Where is Labcyte's headquarters?

    Labcyte's headquarters is located at 170 Rose Orchard Way, San Jose.

  • What is Labcyte's latest funding round?

    Labcyte's latest funding round is Acquired.

  • How much did Labcyte raise?

    Labcyte raised a total of $81.57M.

  • Who are the investors of Labcyte?

    Investors of Labcyte include Beckman Coulter, Notable Labs, Oxford Finance, GE Ventures, Silicon Valley Bank and 13 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.